These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 23083872)
1. Routine transition zone biopsy during active surveillance for prostate cancer rarely provides unique evidence of disease progression. RiChard JL; Motamedinia P; McKiernan JM; DeCastro GJ; Benson MC J Urol; 2012 Dec; 188(6):2177-80. PubMed ID: 23083872 [TBL] [Abstract][Full Text] [Related]
2. Value of transition zone biopsy in active surveillance of prostate cancer. Wang CC; Carter HB; Epstein JI J Urol; 2014 Jun; 191(6):1755-9. PubMed ID: 24316092 [TBL] [Abstract][Full Text] [Related]
3. Regular transition zone biopsy during active surveillance for prostate cancer may improve detection of pathological progression. Wong LM; Toi A; Van der Kwast T; Trottier G; Alibhai SM; Timilshina N; Evans A; Zlotta A; Fleshner N; Finelli A J Urol; 2014 Oct; 192(4):1088-93. PubMed ID: 24742593 [TBL] [Abstract][Full Text] [Related]
4. Biopsy features associated with prostate cancer progression in active surveillance patients: comparison of three statistical models. Iremashvili V; Manoharan M; Rosenberg DL; Soloway MS BJU Int; 2013 Apr; 111(4):574-9. PubMed ID: 22564446 [TBL] [Abstract][Full Text] [Related]
5. Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients. King CR; McNeal JE; Gill H; Presti JC Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):386-91. PubMed ID: 15145152 [TBL] [Abstract][Full Text] [Related]
6. Role of immediate confirmatory prostate biopsy to ensure accurate eligibility for active surveillance. Motamedinia P; RiChard JL; McKiernan JM; DeCastro GJ; Benson MC Urology; 2012 Nov; 80(5):1070-4. PubMed ID: 23107398 [TBL] [Abstract][Full Text] [Related]
7. Pathological features of prostate cancer detected on initial and repeat prostate biopsy: results of the prospective European Prostate Cancer Detection study. Djavan B; Mazal P; Zlotta A; Wammack R; Ravery V; Remzi M; Susani M; Borkowski A; Hruby S; Boccon-Gibod L; Schulman CC; Marberger M Prostate; 2001 May; 47(2):111-7. PubMed ID: 11340633 [TBL] [Abstract][Full Text] [Related]
8. The independent impact of extended pattern biopsy on prostate cancer stage migration. Master VA; Chi T; Simko JP; Weinberg V; Carroll PR J Urol; 2005 Nov; 174(5):1789-93; discussion 1793. PubMed ID: 16217288 [TBL] [Abstract][Full Text] [Related]
9. The ability of prostate-specific antigen (PSA) density to predict an upgrade in Gleason score between initial prostate biopsy and prostatectomy diminishes with increasing tumour grade due to reduced PSA secretion per unit tumour volume. Corcoran NM; Casey RG; Hong MK; Pedersen J; Connolly S; Peters J; Harewood L; Gleave ME; Costello AJ; Hovens CM; Goldenberg SL BJU Int; 2012 Jul; 110(1):36-42. PubMed ID: 22085203 [TBL] [Abstract][Full Text] [Related]
10. The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy. Sebo TJ; Bock BJ; Cheville JC; Lohse C; Wollan P; Zincke H J Urol; 2000 Jan; 163(1):174-8. PubMed ID: 10604340 [TBL] [Abstract][Full Text] [Related]
11. Staging saturation biopsy in patients with prostate cancer on active surveillance protocol. Abouassaly R; Lane BR; Jones JS Urology; 2008 Apr; 71(4):573-7. PubMed ID: 18387385 [TBL] [Abstract][Full Text] [Related]
12. Active surveillance for the management of prostate cancer in a contemporary cohort. Dall'Era MA; Konety BR; Cowan JE; Shinohara K; Stauf F; Cooperberg MR; Meng MV; Kane CJ; Perez N; Master VA; Carroll PR Cancer; 2008 Jun; 112(12):2664-70. PubMed ID: 18433013 [TBL] [Abstract][Full Text] [Related]
13. Increasing the number of biopsies increases the concordance of Gleason scores of needle biopsies and prostatectomy specimens. Divrik RT; Eroglu A; Sahin A; Zorlu F; Ozen H Urol Oncol; 2007; 25(5):376-82. PubMed ID: 17826653 [TBL] [Abstract][Full Text] [Related]
15. Increased detection of clinically significant prostate cancer by additional sampling from the anterior lateral horns of the peripheral zone in combination with the standard sextant biopsy. Miyake H; Sakai I; Harada K; Hara I; Eto H Int J Urol; 2004 Jun; 11(6):402-6. PubMed ID: 15157210 [TBL] [Abstract][Full Text] [Related]
16. Percent of prostate needle biopsy cores with cancer is significant independent predictor of prostate specific antigen recurrence following radical prostatectomy: results from SEARCH database. Freedland SJ; Aronson WJ; Terris MK; Kane CJ; Amling CL; Dorey F; Presti JC; J Urol; 2003 Jun; 169(6):2136-41. PubMed ID: 12771735 [TBL] [Abstract][Full Text] [Related]